Stay updated on Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. There are no apparent changes to the study content or results.
    Difference
    0.1%
    Check dated 2026-03-12T20:21:44.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page. This appears to be a minor site revision.
    Difference
    0.1%
    Check dated 2026-02-12T02:18:56.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1 and removed Revision: v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-04T22:49:33.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added glossary display option; added metadata labels 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T20:25:18.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.3 to v3.3.4; there are no changes to study details, dates, or other content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:07:25.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing California, Massachusetts, and New York; removed separate state location headers and updated the revision from v3.3.2 to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T21:15:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page.